期刊文献+

下肢原发性皮肤弥漫大B细胞淋巴瘤 被引量:1

Primary cutaneous B-cell lymphomas in lower limb:a case report
下载PDF
导出
摘要 报告1例原发性皮肤弥漫大B细胞淋巴瘤。患者男,59岁。因右侧小腿肿块渐增大半年余就诊。皮损组织病理检查示:真皮全层可见大量淋巴细胞及少量组织细胞弥漫性浸润,并与表皮基底层之间有明显无浸润带;增生的淋巴细胞可见较多核分裂象,细胞异形明显。免疫组化染色示:>30%的异形淋巴细胞CD20(+),>80%的异形淋巴细胞波形蛋白(+);CD3、CD68、CD34、CD45RO均(-)。采用放疗及化疗治疗,放疗总剂量为84Gy;化疗采用CHOP(环磷酰胺、长春新碱、多柔比星及泼尼松)方案,经过5次化疗后,疗效显著。 A 59-year-old male patient presented with progressive tumor in his right leg for over half a year. Histopathologic features: many large round lymphocytes and little histiocytes predominated in dermis with obvious uninfiltrated band; these cells were atypical with more mitosis. Immunohistochemical stains indicated tumor cell was positive for CD20 〉 30% with atypia, vimentin 〉80%; and negative for CD3,CD68,CD34 and CD45RO. The patient was treated with radiotherapy (84 Gy in all) and chemotherapy (five course of CHOP regimen), getting a good response.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2008年第12期782-784,共3页 Journal of Clinical Dermatology
关键词 淋巴瘤 B细胞 皮肤 治疗 放射 治疗 化学 lymphomas, B-cells, cutaneous radiotherapy chemotherapy
  • 相关文献

参考文献7

  • 1Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas[J]. Blood, 2005, 105(10): 3768- 3785.
  • 2Santucci M, Pimpinelli N. Primary cutaneous B-cell lymphomas. Current concepts. Ⅰ[J]. Haematologica, 2004, 89(11): 1360-1371.
  • 3Kerl H, Cerroni L. Primary cutaneous B-cell lymphomas: then and now[J]. J Cutan Pathol, 2006, 33 Suppl 1: 1-5.
  • 4Connors JM, Hsi ED, Foss FM. Lymphoma of the Skin[J]. Hematology Am Soc Hematol Educ Program, 2002: 263-282.
  • 5邱丙森.原发性皮肤大B细胞淋巴瘤的研究进展[J].临床皮肤科杂志,2003,32(8):492-494. 被引量:2
  • 6Clarke LE, Bayerl MG, Ehmann WC, et al. Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy[J]. J Cutan Pathol, 2003, 30(7): 459-462.
  • 7万慧颖,王琳,冉玉平,李甘地,周光平.原发性皮肤CD30阳性大细胞淋巴瘤1例[J].中国麻风皮肤病杂志,2003,19(3):215-216. 被引量:3

二级参考文献18

  • 1许越香 李小秋 盛伟琪 许良中 邱丙森 许越香.恶性淋巴瘤的病理形态学[A].许良中,邱丙森,许越香.现代恶性淋巴瘤病理学[M].上海:上海科学技术文献出版社,2002.113.
  • 2Ackerman AB, Nakano S. A critique of classifications of lymphoma in historical perspective and a proposal for how a classification that actually works can be formulated [J]. Am J Dermatopathol, 1999, 21(3): 288-293.
  • 3Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group[J]. Blood, 1994, 84(5):1361-1392.
  • 4Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997[J]. Histopathology, 2000, 36(1): 69-86.
  • 5Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer[J]. Blood, 1997, 90(1): 354-371.
  • 6Norton AJ. Classification of cutaneous lymphoma: a critical appraisal of recent proposals[J]. Am J Dermatopathol, 1999, 21(3):279-287.
  • 7Sander CA, Flaig MJ, Kaudewitz P, et al. The revised European-American Classification of Lymphoid Neoplasms (REAL): a preferred approach for the classification of cutaneous lymphomas[J]. Am J Dermatopathol, 1999, 21(3): 274-278.
  • 8Li S, Griffin CA, Mann RB, et al. Primary cutaneous T cell-rich B-cell lymphoma: clinically distinct from its nodal counterpart?[J]. Mod Pathol, 2001, 14(1): 10-13.
  • 9Chen M, Qiu B, Kong J, et al. Angiotropic T cell lymphoma[J].Chin Med J (Engl), 1998, 111(8): 762-764.
  • 10Willemze R, Beljaards RC, Rijlaarsdam U. Classification of primary cutaneous large cell lymphomas[J]. Dermatol Clin, 1994, 12(2): 361-373.

共引文献3

同被引文献9

  • 1唐莉,罗清礼.眼眶弥漫性大B细胞淋巴瘤2例[J].眼科新进展,2005,25(1):89-89. 被引量:4
  • 2Geelen FA, Vermeer MH, Meijer CJ, et al. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related[J]. J Clin Oncol, 1998, 16(6): 2080-2085.
  • 3Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immuno- histochemistry using a tissue microarray[J]. Blood, 2004, 103 ( 1 ) : 275-282.
  • 4Chang CC,McClintock S, Cleveland RP, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma[J]. Am J Surg Pathol, 2004, 8(4): 464-470.
  • 5Dogan A, Bagdi E, Munson P, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas[J]. Am J Surg Pathol, 2000, 24(6) : 846-852.
  • 6Colomo L, L6pez-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patient s wit h diffuse large B-cell lymphoma[J]. Blood, 2003, 101 ( 1 ) : 78-84.
  • 7Mitrovic Z, Ilic I, Nola M, et al. CD43 expression is an adverse prog- nostic factor in diffuse large B-cell lymphoma[J]. Clin Lymph Myel, 2009, 9(2): 133-13"7.
  • 8Grange F, Beylot-Barry M, Courville P, et al. Primary cutaneous diffuse large Bcell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases[J]. Arch Dermatol, 2007, 143 (9) : 1144-1150.
  • 9刘洁,王涛,马东来,方凯,晋红中.原发性皮肤弥漫大B细胞淋巴瘤,腿型[J].临床皮肤科杂志,2008,37(11):702-704. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部